Axon Enterprise, Inc (NASDAQ:AXON – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday. The company traded as low as $291.11 and last traded at $297.05, with a volume of 423,671 shares traded. The stock had previously closed at $306.44.
Analyst Upgrades and Downgrades
A number of analysts have commented on the stock. Barclays reduced their price objective on shares of Axon Enterprise from $688.00 to $507.00 and set an “overweight” rating for the company in a research note on Monday, November 9th. Citigroup reaffirmed a “market outperform” rating on shares of Axon Enterprise in a research report on Monday, November 2nd. UBS Group raised their target price on Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Royal Bank Of Canada reduced their price objective on shares of Axon Enterprise from $735.00 to $615.00 and set an “outperform” rating for the company in a research note on Friday, November 6th. Finally, Morgan Stanley increased their target price on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $612.18.
View Our Latest Analysis on AXON
Axon Enterprise Stock Performance
The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.60 and a current ratio of 3.00. The firm has a 50 day moving average price of $405.68 and a two-hundred day moving average price of $464.50. The company has a market capitalization of $25.82 billion, a P/E ratio of 101.95, a price-to-earnings-growth ratio of 7.22 and a beta of 1.48.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Friday, November 6th. The biotechnology company reported $1.72 EPS for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The company had revenue of $908.55 million for the quarter, compared to the consensus estimate of $934.33 million. During the same quarter last year, the business earned $1.17 EPS. Axon Enterprise’s quarterly revenue was up 27.8% compared to the same quarter last year. On average, research analysts expect that Axon Enterprise, Inc will post 1.65 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, CEO Patrick Smith sold 10,000 shares of the stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the sale, the chief executive officer directly owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This represents a 0.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 37,397 shares of company stock valued at $21,234,034 over the last quarter. 4.20% of the stock is owned by insiders.
Institutional Trading of Axon Enterprise
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AXON. State Street Corp grew its position in shares of Axon Enterprise by 5,700.2% during the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after buying an additional 209,879,882 shares during the period. Envestnet Asset Management Inc. increased its position in shares of Axon Enterprise by 18,050.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after buying an additional 13,127,348 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its stake in Axon Enterprise by 391,214.9% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock worth $2,952,943,000 after buying an additional 6,987,098 shares during the period. Assenagon Asset Management S.A. raised its stake in Axon Enterprise by 5,022.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock worth $1,802,719,000 after buying an additional 4,183,302 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its holdings in Axon Enterprise by 8,432.6% during the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock worth $1,983,414,000 after acquiring an additional 3,496,493 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.
About Axon Enterprise
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
Featured Articles
- Five stocks we like better than Axon Enterprise
- Grounded at 52-Week Lows: When Will Boeing Stock Take Flight?
- Apple’s Next Margin Defense Could Be Hiding in Your Wallet
- From Berlin to Brussels: Tesla’s $3.3 Billion Robotaxi Gamble
- Target Stock Is Up Over 70%—Has the Easy Money Already Been Made?
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
